Literature DB >> 7535086

A genetic model of melanoma tumorigenesis based on allelic losses.

G J Walker1, J M Palmer, M K Walters, N K Hayward.   

Abstract

Previous karyotypic studies have indicated a possible series of non-random chromosomal events involved in progression of melanoma. We sought to verify and augment this model of melanocyte tumorigenesis by studying allelic deletions of markers mapping to these regions in 30 matched pairs of melanoma and constitutional DNA samples. Polymorphic loci on chromosomes 1, 7, 10, 11, 17, and 21 were analyzed and data combined with those previously obtained for chromosome arms 6q and 9p in the same series of tumours. The most frequent and earliest deletions were found on 9p (57%) and 10q (32%). With the exception of one case, no sample had loss of markers on another chromosome without concomitant loss of markers on 9p or 10q. Losses on 6q were also a frequent (31%) and early event whereas losses of loci on distal 1p (22%) or 11q (26%) occurred only in metastatic melanomas. A "background" rate (0-17%) of allele loss was seen on chromosomes 7, 17, and 21. These data strongly support the previous model based on karyotypic findings in melanocytic lesions. However, we have been able to further, augment that model by delimiting the regions of loss on 10q, to that distal to D10S254, and on 1p, to between D1S243 and D1S160.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535086     DOI: 10.1002/gcc.2870120208

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

Review 3.  Liquid Biopsies for Assessing Metastatic Melanoma Progression.

Authors:  Kelly Huynh; Dave S B Hoon
Journal:  Crit Rev Oncog       Date:  2016

4.  Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.

Authors:  M S Shin; W S Park; S Y Kim; H S Kim; S J Kang; K Y Song; J Y Park; S M Dong; J H Pi; R R Oh; J Y Lee; N J Yoo; S H Lee
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Molecular clonality of in-transit melanoma metastasis.

Authors:  T Nakayama; B Taback; R Turner; D L Morton; D S Hoon
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  Identification of PTEN mutations in metastatic melanoma specimens.

Authors:  J T Celebi; I Shendrik; D N Silvers; M Peacocke
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

7.  Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis.

Authors:  I P Tomlinson; W F Bodmer
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

8.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 9.  Genetic pathways to melanoma tumorigenesis.

Authors:  M R Hussein
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

10.  LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck.

Authors:  Ryo Takagi; Daisuke Nakamoto; Jun-etsu Mizoe; Hirohiko Tsujii
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.